EGFR and non-small cell lung carcinoma: Herein, we review the role of lncRNAs in drug resistance to DDP, taxanes, and EGFR-TKIs in NSCLC and summarize lncRNAs and resistance to other drugs targeting abnormally activated signaling pathways and attenuated immune response in NSCLC prospectively.